Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial
Background: Antihypertensive drugs affect mineral metabolism, inflammation, and the oxidative state. The aim of this study was to evaluate the effects of antihypertensive monopharmacotherapy with diuretics, β-blockers, calcium antagonists (Ca-antagonists), angiotensin-converting enzyme inhi...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2018-09-01
|
| Series: | Nutrients |
| Subjects: | |
| Online Access: | http://www.mdpi.com/2072-6643/10/9/1284 |
| _version_ | 1811324771629006848 |
|---|---|
| author | Joanna Suliburska Katarzyna Skrypnik Monika Szulińska Justyna Kupsz Leszek Markuszewski Paweł Bogdański |
| author_facet | Joanna Suliburska Katarzyna Skrypnik Monika Szulińska Justyna Kupsz Leszek Markuszewski Paweł Bogdański |
| author_sort | Joanna Suliburska |
| collection | DOAJ |
| description | Background: Antihypertensive drugs affect mineral metabolism, inflammation, and the oxidative state. The aim of this study was to evaluate the effects of antihypertensive monopharmacotherapy with diuretics, β-blockers, calcium antagonists (Ca-antagonists), angiotensin-converting enzyme inhibitors (ACE-I), and angiotensin II receptor antagonists (ARBs) on zinc (Zn), iron (Fe), and copper (Cu) status, parameters of oxidative and inflammatory states, and glucose and lipid metabolism in patients with newly diagnosed primary arterial hypertension (AH). Methods: Ninety-eight hypertensive subjects received diuretics, β-blockers, Ca-antagonists, ACE-I, or ARB for three months. Zn, Fe, and Cu concentrations were determined in blood, urine, and hair. Results: A decrease in zinc serum and erythrocyte concentration and an increase in zinc urine concentration were registered after diuretic administration. Ca-antagonists led to a decrease in erythrocyte zinc concentration. A decrease in serum zinc concentration was observed after ACE-I. A decrease in triglyceride serum concentration was noted after ACE-I therapy, and a decrease in tumor necrosis factor-α serum concentration was seen following administration of Ca-antagonists. Hypotensive drugs led to decreases in catalase and superoxide dismutase serum concentrations. Conclusions: Three-months of monotherapy with diuretics, Ca-antagonists, or ACE-I impairs zinc status in patients with newly diagnosed primary AH. Antihypertensive monopharmacotherapy and zinc metabolism alterations affect lipid metabolism, the oxidative state, and the inflammatory state. |
| first_indexed | 2024-04-13T14:21:24Z |
| format | Article |
| id | doaj.art-edac4418ad3d4691a53b902b8f942161 |
| institution | Directory Open Access Journal |
| issn | 2072-6643 |
| language | English |
| last_indexed | 2024-04-13T14:21:24Z |
| publishDate | 2018-09-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Nutrients |
| spelling | doaj.art-edac4418ad3d4691a53b902b8f9421612022-12-22T02:43:28ZengMDPI AGNutrients2072-66432018-09-01109128410.3390/nu10091284nu10091284Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized TrialJoanna Suliburska0Katarzyna Skrypnik1Monika Szulińska2Justyna Kupsz3Leszek Markuszewski4Paweł Bogdański5Institute of Human Nutrition and Dietetics, Poznan University of Life Sciences, Wojska Polskiego St. 31, 60-624 Poznań, PolandInstitute of Human Nutrition and Dietetics, Poznan University of Life Sciences, Wojska Polskiego St. 31, 60-624 Poznań, PolandDepartment of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, Szamarzewskiego St. 82/84, 60-569 Poznań, PolandDepartment of Physiology, Poznan University of Medical Sciences, Święcickiego St. 6, 61-781 Poznań, PolandDepartment of Endocrinology and Metabolic Diseases, Polish Mother’s Memorial Hospital—Research Institute, 281/289 Rzgowska St., 93-338 Łódź, PolandDepartment of Treatment of Obesity, Metabolic Disorders and Clinical Dietetics, Poznan University of Medical Sciences, Szamarzewskiego St. 82/84, 60-569 Poznań, PolandBackground: Antihypertensive drugs affect mineral metabolism, inflammation, and the oxidative state. The aim of this study was to evaluate the effects of antihypertensive monopharmacotherapy with diuretics, β-blockers, calcium antagonists (Ca-antagonists), angiotensin-converting enzyme inhibitors (ACE-I), and angiotensin II receptor antagonists (ARBs) on zinc (Zn), iron (Fe), and copper (Cu) status, parameters of oxidative and inflammatory states, and glucose and lipid metabolism in patients with newly diagnosed primary arterial hypertension (AH). Methods: Ninety-eight hypertensive subjects received diuretics, β-blockers, Ca-antagonists, ACE-I, or ARB for three months. Zn, Fe, and Cu concentrations were determined in blood, urine, and hair. Results: A decrease in zinc serum and erythrocyte concentration and an increase in zinc urine concentration were registered after diuretic administration. Ca-antagonists led to a decrease in erythrocyte zinc concentration. A decrease in serum zinc concentration was observed after ACE-I. A decrease in triglyceride serum concentration was noted after ACE-I therapy, and a decrease in tumor necrosis factor-α serum concentration was seen following administration of Ca-antagonists. Hypotensive drugs led to decreases in catalase and superoxide dismutase serum concentrations. Conclusions: Three-months of monotherapy with diuretics, Ca-antagonists, or ACE-I impairs zinc status in patients with newly diagnosed primary AH. Antihypertensive monopharmacotherapy and zinc metabolism alterations affect lipid metabolism, the oxidative state, and the inflammatory state.http://www.mdpi.com/2072-6643/10/9/1284antihypertensive pharmacotherapymineral metabolismzinc |
| spellingShingle | Joanna Suliburska Katarzyna Skrypnik Monika Szulińska Justyna Kupsz Leszek Markuszewski Paweł Bogdański Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial Nutrients antihypertensive pharmacotherapy mineral metabolism zinc |
| title | Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial |
| title_full | Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial |
| title_fullStr | Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial |
| title_full_unstemmed | Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial |
| title_short | Diuretics, Ca-Antagonists, and Angiotensin-Converting Enzyme Inhibitors Affect Zinc Status in Hypertensive Patients on Monotherapy: A Randomized Trial |
| title_sort | diuretics ca antagonists and angiotensin converting enzyme inhibitors affect zinc status in hypertensive patients on monotherapy a randomized trial |
| topic | antihypertensive pharmacotherapy mineral metabolism zinc |
| url | http://www.mdpi.com/2072-6643/10/9/1284 |
| work_keys_str_mv | AT joannasuliburska diureticscaantagonistsandangiotensinconvertingenzymeinhibitorsaffectzincstatusinhypertensivepatientsonmonotherapyarandomizedtrial AT katarzynaskrypnik diureticscaantagonistsandangiotensinconvertingenzymeinhibitorsaffectzincstatusinhypertensivepatientsonmonotherapyarandomizedtrial AT monikaszulinska diureticscaantagonistsandangiotensinconvertingenzymeinhibitorsaffectzincstatusinhypertensivepatientsonmonotherapyarandomizedtrial AT justynakupsz diureticscaantagonistsandangiotensinconvertingenzymeinhibitorsaffectzincstatusinhypertensivepatientsonmonotherapyarandomizedtrial AT leszekmarkuszewski diureticscaantagonistsandangiotensinconvertingenzymeinhibitorsaffectzincstatusinhypertensivepatientsonmonotherapyarandomizedtrial AT pawełbogdanski diureticscaantagonistsandangiotensinconvertingenzymeinhibitorsaffectzincstatusinhypertensivepatientsonmonotherapyarandomizedtrial |